Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NINDS

A System and Method for Identifying T Cell and Other Epitopes

  • Read more about A System and Method for Identifying T Cell and Other Epitopes
US Application 60/251,216
Filed on 2000-11-29

Intercellular Delivary of a Herpes Simplex Virus VP22 Fusion Protein from Cells Infected with Lentriviral Vectors

  • Read more about Intercellular Delivary of a Herpes Simplex Virus VP22 Fusion Protein from Cells Infected with Lentriviral Vectors
US Application 60/310,012
Filed on 2001-08-02

Differentiation of stem Cells to Pancreatic Endocrine Cells

  • Read more about Differentiation of stem Cells to Pancreatic Endocrine Cells
US Application 60/264,107
Filed on 2001-01-24

Method of Increasing Distribution of Therapeutic Agents

  • Read more about Method of Increasing Distribution of Therapeutic Agents
US Application 60/250,286
Filed on 2000-11-30

COMBINED INHIBITION OF PHOSPHODIESTERASE-4 (PDE-4) AND -3 AS A THERAPY FOR TH1-MEDIATED AUTOIMMUNE DISEASES.

  • Read more about COMBINED INHIBITION OF PHOSPHODIESTERASE-4 (PDE-4) AND -3 AS A THERAPY FOR TH1-MEDIATED AUTOIMMUNE DISEASES.
US Application 60/259,270
Filed on 2000-12-22

Individual Mature Teratoma Stem Cells Generated by Fusion of Two Mature Oocytes in Vitro Can be Induced to Differentiate Into Various

  • Read more about Individual Mature Teratoma Stem Cells Generated by Fusion of Two Mature Oocytes in Vitro Can be Induced to Differentiate Into Various
US Application 60/181,309
Filed on 2000-02-09

Postsynaptic Response By Increasing Intracellular Calcium

  • Read more about Postsynaptic Response By Increasing Intracellular Calcium
US Application 60/275,463
Filed on 2001-03-14

EFFICIENT GENERATION OF MIDBRAIN NEURONS FROM MOUSE EMBRYONIC STEM CELLS

  • Read more about EFFICIENT GENERATION OF MIDBRAIN NEURONS FROM MOUSE EMBRYONIC STEM CELLS
US Application 60/201,005
Filed on 2000-05-01

METHODS OF PROTECTING VASCULATURE FROM DAMAGE BY DIPHTHERIA TOXIN- AND PSEUDOMONAS TOXIN-BASED IMMUNOTOXINS DURING THERAPY

  • Read more about METHODS OF PROTECTING VASCULATURE FROM DAMAGE BY DIPHTHERIA TOXIN- AND PSEUDOMONAS TOXIN-BASED IMMUNOTOXINS DURING THERAPY
US Application 60/212,909
Filed on 2000-06-20

A HIGH-THROUGHOUT METHOD FOR DISCOVERING INHIBITORS AND ACTIVATORS OF VOLTAGE-GATED POTASSIUM CHANNELS

  • Read more about A HIGH-THROUGHOUT METHOD FOR DISCOVERING INHIBITORS AND ACTIVATORS OF VOLTAGE-GATED POTASSIUM CHANNELS
US Application 60/181,692
Filed on 2000-02-10

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • …
  • Next page ››
  • Last page Last »
Subscribe to NINDS
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health